Erlotad 25Mg Tablets
30 Tablet(s) in StripMade by
ADLEY FORMULATION
Dosage
TABLET
Product Summary
| Uses | Non-small cell lung cancer treatment, Pancreatic cancer treatment (with chemotherapy) |
| Therapy | Drugs for chronic idiopathic myelofibrosis, anti-neoplastic |
| Side effects | Rash, Diarrhea, Nausea, Fatigue |
Assurance
available
Regulated
Medical Description
This tablet is a targeted therapy used to slow or stop the growth of certain tumors. It contains erlotinib, which blocks specific growth signals inside abnormal cells. It belongs to a class of medicines called tyrosine kinase inhibitors.
Uses
- Non-small cell lung cancer treatment
- Pancreatic cancer treatment (with chemotherapy)
Contraindications
Side effects
- Rash
- Diarrhea
- Nausea
- Fatigue
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You experience sudden breathing difficulties, cough, or fever, which require immediate evaluation for lung inflammation.
- You develop severe, persistent diarrhea.
- You notice signs of liver problems, such as yellowing of the skin or eyes, dark urine, or upper abdominal pain.
- You experience severe eye pain, redness, or vision changes.
- You smoke or stop smoking during treatment, as changes in smoking status can affect erlotinib levels
Directions for Use
Storage and disposal
Quick Tips
- Take on an empty stomach for optimal absorption
- Avoid grapefruit and grapefruit juice while taking this medicine
- Report any severe rash or skin changes to your doctor immediately
- Keep all scheduled doctor visits for monitoring
- Inform all healthcare providers that you are taking this medicine
- If you smoke, tell your doctor, as smoking can reduce how well this medicine works
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 24].
- electronic medicines compendium (emc). Tarceva 150 mg film-coated tablets - Summary of Product Characteristics (SmPC) [Internet]. Sandwich: Roche Products Limited; 2023 [cited 2026 Aug 24].
- European Medicines Agency (EMA). Tarceva EPAR - Product Information [Internet]. Amsterdam: EMA; 2020 [cited 2026 Aug 24].
- Malta Medicines Authority. Tarceva summary of product characteristics [Internet]. Valletta: Medicines Authority; [cited 2026 Aug 24].
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ERLOTAD
Vendor Details
Fulfillment Information: Erlotad Tablet (30) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
